“…For example, under ischaemic conditions in mammalian tissues, respiration is halted and the ATP synthase reverses in response to decreased mitochondrial membrane potential, partially compensating for its loss by utilizing ATP produced by glycolysis. To limit the detrimental depletion of cellular ATP caused by an ATP-consuming F-ATP synthase (Rouslin et al ., 1986; Jennings et al ., 1991; St-Pierre et al ., 2000), the activity of this enzyme is regulated by a short naturally occurring protein, the inhibitory factor 1 (IF1) (Pullman and Monroy, 1963; Walker, 1994). IF1 specifically inhibits the ATPase activity with no effect on ATP synthesis (Pullman and Monroy, 1963; Asami et al ., 1970), although some authors propose an inhibitory effect of IF1 on both ATP synthase modes (Harris et al ., 1979; Schwerzmann and Pedersen, 1981; Formentini et al ., 2012; Garcia-Bermudez and Cuezva, 2016).…”